What To Watch In Pay-For-Delay Trial Against Merck, Glenmark
By Cara Salvatore ( April 17, 2023, 7:22 PM EDT) -- Merck and generic-drug maker Glenmark are set to start a trial this week on claims that they gouged buyers of Merck's blockbuster cholesterol drug Zetia by forging a pay-for-delay deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.